Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2- HIV Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06843902
What this trial is testing

Improving Coronary Vascular Health in Women

Who this might be right for
HIV-1-infectionCoronary Microvascular DysfunctionMetabolic Disease
Massachusetts General Hospital 80
Not applicableStudy completedNCT00002207
What this trial is testing

A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00637572
What this trial is testing

Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss

Who this might be right for
HIV InfectionsCachexiaAnorexia+2 more
Endo USA Inc., a Keenova Therapeutics Company 63
Large-scale testing (Phase 3)Study completedNCT01448707
What this trial is testing

A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment

Who this might be right for
Human Immunodeficiency Virus (HIV) InfectionsAcquired Immunodeficiency Syndrome (AIDS) Virus
Janssen-Cilag International NV 274
Large-scale testing (Phase 3)Study completedNCT00311298
What this trial is testing

Nutrition, Diabetes and Pulmonary TB/HIV

Who this might be right for
TuberculosisHIVDiabetes
University of Copenhagen 1,250
Early research (Phase 1)UnknownNCT00013572
What this trial is testing

HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults

Who this might be right for
HIV InfectionsHIV Seronegativity
Walter Reed Army Institute of Research (WRAIR) 36
Not applicableStudy completedNCT00002330
What this trial is testing

Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Roche Global Development 280
Early research (Phase 1)Study completedNCT00393328
What this trial is testing

Bioequivalence Study of Atazanavir 300 mg Capsule

Who this might be right for
HIV Infections
Bristol-Myers Squibb 46
Testing effectiveness (Phase 2)Study completedNCT00371592
What this trial is testing

Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

Who this might be right for
HIV InfectionsHerpesvirus 2, Human
National Institute of Allergy and Infectious Diseases (NIAID) 50
Large-scale testing (Phase 3)Study completedNCT00330304
What this trial is testing

Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children

Who this might be right for
Tuberculosis
University of Cape Town 450
Post-approval studies (Phase 4)Study completedNCT00362687
What this trial is testing

GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance

Who this might be right for
HIV Infections
Gilead Sciences 50
Not applicableStudy completedNCT00005915
What this trial is testing

A Comparison of Two Anti-HIV Treatment Plans

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 480
Large-scale testing (Phase 3)Study completedNCT00194519
What this trial is testing

Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission

Who this might be right for
HIV InfectionHerpes Simplex, GenitalSexually Transmitted Diseases
University of Washington 3,408
Early research (Phase 1)Study completedNCT01231542
What this trial is testing

Phase 1, Open Label, Two Arm, Fixed Sequence Study to Evaluate the Effect of Rifampin and Rifabutin on GSK1349572 Pharmacokinetics in Healthy Male and Female Volunteers

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 27
Testing effectiveness (Phase 2)Study completedNCT01252641
What this trial is testing

Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Subjects

Who this might be right for
HIVHIV Infection
Sangamo Therapeutics 21
Large-scale testing (Phase 3)Study completedNCT00105079
What this trial is testing

GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection

Who this might be right for
HIV Infections
Hoffmann-La Roche 337
Not applicableUnknownNCT06565013
What this trial is testing

Chemsex Health Evaluation With Extended Release System for HIV Treatment

Who this might be right for
HIV
Clinique Médicale L'Actuel 50
Early research (Phase 1)Study completedNCT05230368
What this trial is testing

Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load

Who this might be right for
HIV-1-infection, Subtype b
ANRS, Emerging Infectious Diseases 9
Early research (Phase 1)Study completedNCT02109354
What this trial is testing

Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults

Who this might be right for
HIV Infection
HIV Vaccine Trials Network 202
Early research (Phase 1)Study completedNCT01336829
What this trial is testing

TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.

Who this might be right for
Hepatitis CHIV
Tibotec Pharmaceuticals, Ireland 33
Next Page